Axiom Investors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-444,508
| Closed | -$34.6M | – | 137 |
|
|
2024
Q3 | $34.6M | Buy |
+444,508
| New | +$34.6M | 0.3% | 43 |
|
|
2023
Q4 | – | Sell |
-10,600
| Closed | -$718K | – | 137 |
|
|
2023
Q3 | $718K | Sell |
10,600
-921,989
| -99% | -$62.4M | 0.01% | 121 |
|
|
2023
Q2 | $66.7M | Buy |
932,589
+45,318
| +5% | +$3.24M | 0.99% | 30 |
|
|
2023
Q1 | $61.6M | Sell |
887,271
-1,821,139
| -67% | -$126M | 1.01% | 31 |
|
|
2022
Q4 | $184M | Buy |
2,708,410
+365,550
| +16% | +$24.8M | 3.61% | 6 |
|
|
2022
Q3 | $128M | Buy |
2,342,860
+820,354
| +54% | +$45M | 2.7% | 11 |
|
|
2022
Q2 | $101M | Buy |
+1,522,506
| New | +$101M | 3.02% | 10 |
|
|
2020
Q4 | – | Sell |
-1,332,070
| Closed | -$73M | – | 128 |
|
|
2020
Q3 | $73M | Buy |
1,332,070
+56,150
| +4% | +$3.08M | 1.18% | 22 |
|
|
2020
Q2 | $67.5M | Buy |
1,275,920
+157,450
| +14% | +$8.33M | 1.33% | 22 |
|
|
2020
Q1 | $50M | Buy |
1,118,470
+31,890
| +3% | +$1.42M | 1.27% | 20 |
|
|
2019
Q4 | $54.2M | Sell |
1,086,580
-129,790
| -11% | -$6.47M | 1.26% | 22 |
|
|
2019
Q3 | $54.2M | Buy |
1,216,370
+208,610
| +21% | +$9.3M | 1.46% | 23 |
|
|
2019
Q2 | $41.6M | Buy |
1,007,760
+238,145
| +31% | +$9.83M | 1.14% | 29 |
|
|
2019
Q1 | $31.1M | Sell |
769,615
-450
| -0.1% | -$18.2K | 0.96% | 29 |
|
|
2018
Q4 | $29.2M | Buy |
+770,065
| New | +$29.2M | 1.02% | 29 |
|